MPA (Methiopropamine) is a synthetic compound structurally related to methamphetamine, but with a thiophene ring replacing the phenyl ring. It has become a subject of interest in pharmacological and toxicological studies due to its stimulant-like effects and distinct chemical structure. Researchers utilize MPA to explore mechanisms of monoamine transport, structure-activity relationships, and stimulant behavior in laboratory settings.

• Monoamine Transporter Studies: MPA is used to study how it inhibits the reuptake of dopamine and norepinephrine, offering insight into its stimulant-like properties and how small structural changes affect neurotransmitter systems.

• Structure-Activity Relationship (SAR) Research: As a methamphetamine analogue with a thiophene substitution, MPA helps researchers investigate the influence of structural modifications on pharmacological activity.

• CNS Stimulant Modeling: MPA allows scientists to explore the stimulant class without the regulatory constraints of Schedule II substances, providing a legal analogue for behavioral and toxicological models.

• Neurotoxicity Testing: In vitro studies use MPA to assess potential cytotoxic effects on neuronal cell lines, helping to identify neurochemical risks of thiophene-substituted stimulants.

• Pharmacokinetics Exploration: MPA provides a model for studying absorption, distribution, metabolism, and excretion (ADME) in synthetic stimulants.

• Metabolism Pathways Identification: Researchers analyze how the body processes MPA in both rodent liver microsomes and cell lines to determine metabolic stability and pathways.

• Reference Standard in Forensics: MPA can be used as a comparative standard in forensic toxicology when identifying unknown stimulants with similar mass spectra or behavior.

The legal status of MPA varies globally and is subject to changes in psychoactive substance regulations. While it remains unscheduled in some countries, others have added it to controlled substances lists. It is essential for researchers to understand the jurisdiction-specific laws before acquiring or working with MPA.

• United States: MPA is not a federally scheduled substance but may be considered illegal under the Federal Analog Act if intended for human consumption. It is often permitted for legitimate laboratory research.

• United Kingdom: MPA was previously legal but was banned under the Psychoactive Substances Act 2016. Possession, supply, or production for non-research purposes is prohibited.

• European Union: Regulations differ. Some countries like Germany classify MPA as a controlled substance, while others may not regulate it directly but apply analogue laws.

• Australia and New Zealand: MPA is controlled under analogue provisions in Australia and may be treated as a derivative of methamphetamine in New Zealand.

• Canada: MPA is not explicitly scheduled, but importation or possession for non-laboratory use could fall under controlled substance analogues.

• RC Plug Policy: We sell MPA strictly for non-human, research-only applications. Buyers are responsible for complying with local regulations.

• Recommended Due Diligence: Prior to ordering, always consult national scheduling databases or regulatory bodies to confirm the legality of MPA in your area.

MPA and methamphetamine share a core structural motif—a substituted amphetamine backbone—but differ significantly in their aromatic ring structure. This subtle yet crucial change impacts their pharmacology, metabolism, and receptor binding profiles.

• Ring Substitution: MPA replaces methamphetamine’s phenyl ring with a thiophene ring, introducing sulfur and altering electron density and steric properties.

• Receptor Affinity Shift: The substitution affects how the molecule binds to monoamine transporters, typically resulting in reduced dopaminergic potency compared to methamphetamine.

• Pharmacodynamic Differences: Methamphetamine acts as a strong releaser of monoamines, while MPA primarily functions as a reuptake inhibitor with a weaker releasing component.

• Lipophilicity and Absorption: MPA’s sulfur-containing ring may influence lipid solubility, impacting its membrane permeability and absorption rate in in vitro studies.

• Chemical Stability: MPA may show increased or decreased stability in various solvents or biological matrices compared to methamphetamine due to its thiophene core.

• Forensic Distinction: MPA has a distinct mass spectrometric profile, allowing it to be clearly differentiated from methamphetamine in toxicological screenings.

• Legal Implications: The structural deviation exempts MPA from direct scheduling under certain methamphetamine-specific laws in countries with strict regulatory frameworks.

Proper storage of MPA is critical to preserving its chemical integrity, ensuring accurate experimental outcomes, and avoiding degradation from environmental factors. Researchers should follow strict storage guidelines to maintain stability over time.

• Cool Temperature: MPA should be stored in a cool environment, ideally between 2°C and 8°C. Room temperature storage may be acceptable short-term but increases the risk of degradation over time.

• Low Humidity: Humidity can lead to hydrolysis or clumping of the powder. Use desiccant packs within storage containers to reduce moisture exposure.

• Light Protection: Exposure to UV light can degrade thiophene-based compounds. Store MPA in amber glass containers or light-blocking pouches.

• Airtight Sealing: Always seal MPA in airtight, tamper-proof containers. This prevents exposure to oxygen and atmospheric contaminants that can oxidize the material.

• Avoid Frequent Temperature Shifts: Repeated removal and exposure to fluctuating temperatures can introduce condensation, especially when taken from cold storage.

• Labeling and Documentation: Ensure all storage containers are properly labeled with batch number, concentration, and storage conditions for compliance and safety.

• Shelf Life Monitoring: When stored under optimal conditions, MPA typically remains stable for up to 24 months. Periodically test retained samples for purity validation.

In its purest form, MPA is a crystalline compound typically described as a white to off-white powder. Its appearance may vary slightly depending on synthesis method, purity level, and storage history, but its physical characteristics are generally consistent and recognizable.

• Color: High-purity MPA presents as white or very pale beige. Discoloration may suggest impurity or degradation and should be investigated before use.

• Texture: The powder is fine and may appear slightly crystalline under magnification. Clumping may indicate moisture exposure, requiring proper drying or replacement.

• Smell: MPA is generally odorless, though a faint chemical odor may be present in some batches. A strong or unpleasant smell can signal contamination.

• Solubility Properties: MPA dissolves readily in polar organic solvents like ethanol, methanol, and DMSO. Insolubility in water is expected due to its lipophilic thiophene ring.

• No Visible Contaminants: The compound should appear uniform without visible fibers, dark particles, or residue. Impurities often signal improper synthesis or storage.

• Visual Assay Tools: Under UV light or when recrystallized, MPA can be further verified for structural consistency, though proper identification requires spectroscopy or chromatography.

• Packaging Indicators: RC Plug packages MPA in sterile, non-reactive materials. Discoloration or compromise in packaging integrity should be reported immediately.

MPA is suitable for both in vitro (test tube/cell culture) and in vivo (live organism) research, but its use in either context requires strict adherence to ethical, safety, and scientific protocols. Due to its stimulant-like properties and structural similarity to controlled substances, researchers often explore its pharmacological behavior in models mimicking central nervous system (CNS) stimulation. However, in vivo testing should be carried out only with appropriate regulatory clearance.

• In Vitro Applications: MPA is widely used in receptor-binding assays, neurotransmitter reuptake inhibition models, and cytotoxicity testing on neuronal cell lines, making it a versatile compound for controlled laboratory settings.

• In Vivo Usage Restrictions: While in vivo testing can reveal behavioral and systemic effects, this research requires animal ethics committee approval and adherence to all local legislation, particularly where stimulant analogues are restricted.

• Blood-Brain Barrier Penetration: Researchers studying CNS activity may explore MPA’s lipophilic structure to assess its potential for crossing the blood-brain barrier in mammalian models.

• Behavioral Studies: In controlled animal models, MPA may be studied for locomotor activation, reward-based behaviors, and stimulant-induced anxiety analogues.

• Toxicological Profiling: Both in vitro and in vivo research contribute to understanding the potential for neurotoxicity or organ-specific toxicity of MPA over time.

• Dose-Response Relationships: Researchers often use in vitro models to determine effective concentrations before transitioning to in vivo models, minimizing risk while maximizing data accuracy.

Yes, MPA is susceptible to degradation over time if exposed to unfavorable storage conditions such as moisture, oxygen, and temperature fluctuations. Understanding the degradation pathways of MPA is crucial for maintaining research integrity, ensuring that the compound used in studies is chemically consistent with original specifications.

• Oxidative Degradation: Prolonged exposure to oxygen, especially in the presence of light, can lead to oxidation of the thiophene ring, resulting in a loss of potency or formation of unknown byproducts.

• Moisture-Induced Hydrolysis: Humid environments can cause MPA to clump or hydrolyze, particularly if the product is not stored in sealed, desiccated containers.

• Thermal Instability: Although relatively stable at room temperature, long-term exposure to elevated temperatures can accelerate degradation and chemical instability.

• pH Sensitivity: MPA’s stability may be altered in highly acidic or basic environments, making it less suitable for storage in non-neutral solutions.

• Changes in Appearance: Physical signs of degradation may include discoloration, changes in texture, or crystallization inconsistencies.

• Analytical Testing: Periodic testing via HPLC, NMR, or GC-MS is essential to monitor degradation over storage periods, especially for research-grade compounds.

• Stability Timeline: When stored correctly (cool, dry, and protected from light), MPA can maintain stability for up to 24 months, although shorter durations should be assumed in suboptimal conditions.

Selecting the correct solvent for MPA is essential for successful solubilization, especially in laboratory applications such as chromatography, spectroscopy, or biological assays. MPA is moderately lipophilic, meaning it dissolves well in polar organic solvents but poorly in water. Solubility and solvent compatibility must be validated based on research needs.

• Ethanol: A widely used solvent in research, ethanol dissolves MPA efficiently and is compatible with many bioassays, though it may require filtration for particulate removal.

• Dimethyl Sulfoxide (DMSO): Highly effective at solubilizing MPA, DMSO is ideal for in vitro research due to its ability to penetrate cell membranes and its chemical stability.

• Methanol: A polar solvent that offers high solubility for MPA, often used in HPLC or spectrophotometric analysis due to its purity and low UV absorbance.

• Acetonitrile: Suitable for analytical purposes, especially in chromatography. It offers low viscosity and is compatible with MPA when used in proper ratios.

• Avoid Water: MPA is sparingly soluble in water due to its thiophene ring structure, making it unsuitable for aqueous solutions unless co-solvents are used.

• Filtration and pH Adjustment: Always filter prepared solutions and adjust pH if needed to maintain chemical stability and avoid precipitation or degradation.

• Solvent Purity Matters: Use only high-purity, research-grade solvents to ensure consistent solubility and avoid introducing impurities into your research.

Determining the correct dosage of MPA for experimental procedures depends on the research context, model type, and intended outcomes. Whether for receptor-binding affinity, behavioral studies, or toxicity assessment, dosage must be calibrated with scientific precision to avoid skewing results or introducing biological artifacts.

• In Vitro Concentrations: Researchers typically start with micro- to millimolar concentrations (e.g., 1 μM–100 μM) depending on the sensitivity of the assay or cell line.

• In Vivo Dosing: Animal models require conversion from in vitro efficacy to per-kilogram body weight doses, often beginning at sub-threshold levels and titrating up for effect monitoring.

• Literature Review: Published pharmacology papers and prior toxicity studies are used as benchmarks for establishing safe and effective dose ranges.

• Toxicity Thresholds: Dose escalation studies help determine MPA’s median lethal dose (LD50) or no-observed-adverse-effect level (NOAEL), which guide future research.

• Delivery Route Considerations: Whether MPA is administered orally, intravenously, or intraperitoneally affects its bioavailability, requiring dose adjustments for accurate modeling.

• Assay Sensitivity: Enzymatic and receptor-based assays may require different dosing protocols to avoid saturation or suppression effects.

• Control Comparisons: Including reference stimulants like amphetamine or 3-FPM allows for comparative dosing and efficacy modeling in stimulant-related research.

MPA’s neurotoxic potential remains under investigation, but initial studies suggest that, like other stimulant analogues, it may exhibit neurotoxicity under certain conditions or concentrations. It is vital that researchers explore this aspect using rigorous, controlled methodologies to understand its safety profile in both acute and chronic exposure models.

• Dopaminergic Stress: As a dopamine reuptake inhibitor, MPA can lead to elevated synaptic dopamine, which may induce oxidative stress and mitochondrial damage in dopaminergic neurons.

• Oxidative Burden: The thiophene ring may undergo metabolic oxidation, potentially forming reactive oxygen species (ROS) and contributing to cellular toxicity in neuronal models.

• Cytotoxicity in Cell Lines: Some studies using neuroblastoma or glial cell cultures have shown reduced viability with high MPA concentrations, though this is dose- and time-dependent.

• Glutamate Dysregulation: Similar to other stimulants, MPA may affect glutamate pathways, raising the potential for excitotoxic effects in overexposed neural tissue.

• Lack of Long-Term Data: There is limited longitudinal data on repeated low-dose exposure to MPA, making chronic neurotoxicity an open area of research.

• Comparison to Methamphetamine: MPA is generally considered less neurotoxic than methamphetamine due to its weaker monoamine releasing profile, though care must still be exercised in extrapolating findings.

• Protective Protocols: Researchers often co-administer antioxidants or neuroprotective agents in exploratory models to assess MPA’s contribution to neurodegeneration under stress conditions.

MPA may be used in combination with other compounds in scientific studies, particularly for comparative or interaction-based research. However, combining research chemicals carries increased risks and complexities, especially when studying pharmacodynamics or potential synergistic effects. Proper risk assessment and ethical oversight are critical when using MPA in any co-administration or interaction model.

• Drug-Drug Interaction Models: MPA can be evaluated alongside other stimulants or depressants to observe interactions at transporter, receptor, or enzymatic levels.

• Comparative Receptor Affinity Studies: MPA is sometimes co-administered with compounds like 3-FPM or modafinil to compare affinities for dopamine, norepinephrine, and serotonin transporters.

• Cumulative Toxicity Monitoring: Co-exposure models can assess whether MPA exacerbates cytotoxicity or behavioral abnormalities when combined with structurally or functionally similar compounds.

• Metabolic Inhibition or Enhancement: MPA’s metabolism may be altered in the presence of other substances, especially those affecting cytochrome P450 enzymes — requiring close monitoring of pharmacokinetics.

• Synergistic CNS Effects: When paired with other CNS stimulants, there may be enhanced activity in locomotion assays or behavioral sensitization models.

• Antagonist Control Studies: MPA can be administered with dopamine receptor antagonists to investigate whether observed effects are dopamine-specific, helping map its mechanism of action.

• Use with Caution: Mixing chemicals in uncontrolled settings may lead to unpredictable results. All compound combinations should be validated with dose-response and cytotoxicity pre-screens.

At RC Plug, we provide MPA with a minimum certified purity of ≥98%, verified by independent third-party laboratories. Purity is one of the most critical aspects in research-grade compounds, as even small impurities can skew data, interfere with results, or introduce unknown variables in pharmacological models.

• Third-Party Lab Tested: All MPA batches undergo rigorous analytical testing by independent labs using methods such as gas chromatography-mass spectrometry (GC-MS) and high-performance liquid chromatography (HPLC).

• Batch Consistency: We maintain batch-specific purity guarantees and ensure minimal variance across production lots, supporting repeatable and reliable research results.

• No Fillers or Cutting Agents: Our MPA is never diluted or adulterated with inactive substances, unlike materials sourced from unverified or grey-market suppliers.

• Analytical Reports Available: Upon request, we provide certificates of analysis (COAs) detailing impurity profiles, retention times, and testing methodology.

• Quality Assurance Protocols: Each batch is logged, sealed, and inspected for physical conformity and documentation accuracy before distribution.

• Purity Verification by Customers: Many research teams independently validate our purity claims using in-house techniques, confirming our reliability and quality standards.

Yes, every batch of MPA that we distribute is tested to ensure it meets our stringent research-grade standards. We employ both internal quality control procedures and partner with certified third-party analytical labs to validate compound identity, purity, and safety before release.

• Full Identity Verification: Each batch is confirmed using structural fingerprinting techniques such as NMR (nuclear magnetic resonance) and infrared spectroscopy to match the exact molecular profile of MPA.

• Impurity Screening: We screen for common and uncommon contaminants, including synthesis byproducts, residual solvents, and heavy metals, to ensure safety and reliability in lab experiments.

• Reproducibility Focus: Our testing protocols ensure batch-to-batch consistency, supporting long-term projects and repeat studies without introducing variable impurities.

• Chain of Custody Documentation: Each test is tied to a documented manufacturing and handling log, ensuring traceability throughout the supply chain.

• Rapid Response to Defects: If any quality deviation is detected, the batch is immediately recalled and replaced — maintaining trust and accountability with every shipment.

• Compliance with Research Standards: Our quality control program aligns with international research guidelines for chemical sourcing, particularly in toxicology and neuroscience.

At RC Plug, we take packaging seriously — both for chemical protection and customer privacy. MPA is packaged in industry-grade materials designed to preserve chemical integrity throughout transit and shield the contents from environmental stress, contamination, or tampering.

• Vacuum-Sealed Containers: Each unit of MPA is sealed in moisture-proof, oxygen-resistant pouches that prevent contamination and degradation during shipping.

• Opaque and Non-Descriptive: All outer packaging is plain and unbranded, with no indication of the contents or company name — ensuring full discretion during transport and customs inspection.

• Anti-Tamper Measures: Inner containers feature security seals to detect any unauthorized access. These seals also confirm that your product has not been altered post-dispatch.

• Double Layer Protection: We use a two-tier system — an inner chemical-grade container and an outer mailing pouch or box — to protect the product from impact, pressure, or tearing.

• Labeling for Research Use Only: Each container is marked with basic identifiers (batch number, quantity, and research-use disclaimer) to comply with laboratory documentation standards.

• Temperature and Humidity Resistant Materials: Packaging materials are chosen to endure long-distance travel, avoiding chemical shifts due to heat, cold, or humidity exposure.

MPA is a highly versatile research compound used in several domains of scientific investigation, particularly within psychopharmacology, toxicology, and behavioral neuroscience. Due to its stimulant-like activity and structural resemblance to methamphetamine, it serves as a comparative tool in studies that require a non-controlled stimulant alternative.

• Neurotransmitter Reuptake Studies: MPA’s ability to inhibit dopamine and norepinephrine transporters makes it a model compound for monoamine reuptake inhibition assays.

• Behavioral Pharmacology: In animal studies, MPA is used to assess locomotor stimulation, reward-seeking behavior, and anxiety-like responses — mimicking effects seen with classical stimulants.

• Toxicology and Cytotoxicity Models: MPA is tested for acute and sub-acute toxic effects in cellular and animal models, offering insights into stimulant-induced organ and neuron stress.

• Comparative SAR (Structure-Activity Relationship): As a thiophene analogue, MPA helps elucidate how subtle molecular changes influence pharmacodynamics relative to other amphetamine-type stimulants.

• Drug Metabolism Research: Researchers study MPA’s metabolic breakdown, identifying active metabolites and enzyme pathways, particularly those involving cytochrome P450 enzymes.

• Forensic Reference Tool: MPA serves as a calibration and comparison compound in forensic laboratories when analyzing unknown samples that mimic stimulant behavior.

• In Vitro Cell Response Testing: MPA is used to observe concentration-dependent effects on human cell cultures, assisting in dose-response curve generation and safety threshold determination.

Absolutely not. MPA (Methiopropamine) sold by RC Plug is strictly intended for laboratory research purposes only. Human or veterinary consumption is explicitly prohibited under our policy and international research standards. Misuse of MPA can lead to serious health risks and potential legal consequences.

• Not Approved for Human Use: MPA is not approved by the FDA, EMA, or any regulatory agency for therapeutic or recreational use in humans or animals.

• Potential Toxicity: Human exposure to research-grade MPA may lead to unknown side effects, including cardiovascular stress, neurological disruption, or toxic buildup of metabolites.

• Legal Implications: Using or distributing MPA for human consumption may violate analogue laws or controlled substance regulations in many countries, even if the compound itself is unscheduled.

• Formulation Safety Concerns: Our MPA is packaged and produced under chemical—not pharmaceutical—conditions, meaning it may contain solvent residues not safe for ingestion.

• Policy Enforcement: RC Plug reserves the right to refuse sales to individuals suspected of intending to misuse research products in violation of our terms and conditions.

• Strict Lab Use Labeling: Every unit is clearly labeled “Not for Human Consumption” to prevent accidental misuse or regulatory confusion.